Ticker Short Interest

IOVA Short Interest Intelligence

Iovance Biotherapeutics Inc positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

IOVA is classified as Neutral. Latest reported short interest is 100.5M shares; short interest changed -2.9%, price moved +4.2% since the previous report, short interest is in the 14th percentile, and days to cover is in the 43th percentile. Trend context is mixed.

Setup Score27/100Neutral
Reported Short Interest100.5M-2.9% vs prior report
Days To Cover7.1042.86 percentile
Price Reaction+4.2%since previous short report
Squeeze Pressure19crowding, trend, and pressure
Bearish Conviction11shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

19

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

11

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

27

Latest short interest is 100.5M shares and days to cover is 7.10.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

IOVA Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 100526623 103489642 -2.9% 7.10 14159736
15 Jun 2026 103489642 104249751 -0.7% 7.90 13107577
29 May 2026 104249751 106608353 -2.2% 8.19 12722798
15 May 2026 106608353 114711667 -7.1% 6.00 17782438
30 Apr 2026 114711667 108804045 5.4% 9.15 12535651
15 Apr 2026 108804045 110832243 -1.8% 6.54 16639967
31 Mar 2026 110832243 115070206 -3.7% 9.47 11697703

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.